Chemical antifoaming agents are used for the destruction of excessive foam in biological processes. This is because foaming can transform into major problem at the time of large-scale recombinant protein bioprocesses. Antifoams are available in several forms with a range of properties and varied foam destruction capabilities, with the ones needed several times becoming depleted over time.
Antifoaming agents may contain surfactants that may include hydrophobic solids dispersed in carrier oil, liquid single components or solids, and aqueous suspensions or emulsions. Antifoams can affect the growth rates of prokaryotic as well as eukaryotic organisms along with changing surface properties such as lipid content which results in change in permeability.
Download PDF Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15233
On the other hand, certain concentrations of antifoams are related to detrimental effect on cells and protein production. The effects of these concentrations are dependent on the protein being expressed. This emphasizes the importance of optimizing the concentration of antifoams for bioprocesses. However, very less information is available regarding the biological effects of antifoaming agents and most of it is not recent.
Bioprocess antifoam market generally encounters an issue during the biological process which is excessive foaming. Bioprocess antifoam market thus requires a foam control agent, termed as antifoam. An antifoam can be actively used during fermentation or any other process when foaming is an inherent issue.